A carregar...

Once-daily MMX mesalamine for the treatment of mild-to-moderate ulcerative colitis

First-line therapies in the treatment of patients with mild-to-moderate ulcerative colitis are sulfasalazine or one of the mesalamine derivatives. Mesalamine is popular given its safety profile and reasonable efficacy in many patients. However, compliance is poor with regimens demanding large number...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kedia, Prashant, Cohen, Russell D
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2007
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2376087/
https://ncbi.nlm.nih.gov/pubmed/18473016
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!